Author

Santosh Raja Kanade

University of HyderabadORCID 0000-0002-2184-9973Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Aishwarya SwainiD· 2 shared Archana PaniD· 2 shared Biji ChatterjeeiD· 2 shared Bramanandam ManavathiiD· 2 shared Chandrashekhar G. JoshiiD· 2 shared Jagadeesha PoyyaiD· 2 shared Kirankumar NallaiD· 2 shared A. T. Dhanya· 1 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Aishwarya SwainORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Ellagic acid: a potential inhibitor of enhancer of zeste homolog-2 and protein arginine methyltransferase-5

Kirankumar Nalla, Biji Chatterjee, Jagadeesha Poyya, Aishwarya Swain, Krishna Ghosh, Archana Pan, Chandrashekhar G. Joshi, Bramanandam Manavathi, Santosh Raja Kanade

This study identifies ellagic acid as an inhibitor of EZH2 and PRMT5:MEP50, showing reduced histone modifications and tumor growth in mouse models.

Cancer Genetics · Sep 2, 2025Peer-reviewedCancer Biology

Green Synthesis of Different Zein nanoparticles Characterization and In vitro Release studies

A. T. Dhanya, N. Vaagdevi, M. Archana, Santosh Raja Kanade

The paper synthesizes zein nanoparticles using green methods with polysaccharides and evaluates their morphology, stability, and drug release properties using herbal extracts.

bioRxiv · Sep 1, 2025 · PreprintBiochemistry

Epigallocatechin-3-gallate inhibit the protein arginine methyltransferase 5 and Enhancer of Zeste homolog 2 in breast cancer both in vitro and in vivo

Kirankumar Nalla, Biji Chatterjee, Jagadeesha Poyya, Aishwarya Swain, Krishna Kanta Ghosh, Archana Pan, Chandrashekhar G. Joshi, Bramanandam Manavathi, Santosh Raja Kanade

This study shows that EGCG inhibits PRMT5 and EZH2 in breast cancer cells and xenografts, reducing histone repressive marks and inducing apoptosis and autophagy.

Archives of Biochemistry and Biophysics · Nov 22, 2024Peer-reviewedCancer Biology